Showing results (241-250 of 352) with videos related to

Sort By:
Pageof 36
Advances in Wound Care|February 12, 2025
An Open-Label, Interventional, Prospective, Real-World Evidence Study to Evaluate a Multimodal Wound Matrix in Patients with Refractory WoundsYadwinder Dhillon, Gerit Mulder, Keyur Patel, et al.
Aging|September 4, 2023
Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patientsFakhar Ali Qazi Arisar, Shiyi Chen, Catherine Chen, et al.
American Journal of Hematology|September 2, 2022
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patientsGautam Borthakur, Farhad Ravandi, Keyur Patel, et al.
The Lancet. Digital Health|February 26, 2022
Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort studySoren Sabet Sarvestany, Jeffrey C Kwong, Amirhossein Azhie, et al.
American Journal of Hematology|July 21, 2018
Sorafenib Combined with 5-azacytidine in Older Patients with Untreated FLT3-ITD Mutated Acute Myeloid LeukemiaMaro Ohanian, Guillermo Garcia-Manero, Mark Levis, et al.
Frontiers in Oncology|November 16, 2020
Emergence of BCR-ABL1 Fusion in AML Post-FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance - A Case SeriesAhmad S Alotaibi, Musa Yilmaz, Sanam Loghavi, et al.
Hepatology (Baltimore, Md.)|March 8, 2011
High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patientsKeyur Patel, Joseph E Lucas, J Will Thompson, et al.
American Journal of Hematology|July 4, 2014
Gemtuzumab ozogamicin with fludarabine, cytarabine, and granulocyte colony stimulating factor (FLAG-GO) as front-line regimen in patients with core binding factor acute myelogenous leukemiaGautam Borthakur, Jorge E Cortes, Elihu E Estey, et al.
Oncotarget|February 13, 2016
Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agentsKoichi Takahashi, Keyur Patel, Carlos Bueso-Ramos, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 14, 2025
Beyond the HIV Organ Policy Equity Act: Roadmap to expanding kidney and liver transplants for people with human immunodeficiency virus utilizing grafts from donors with human immunodeficiency virusTzu-Hao Lee, Kara Wegermann, Ken Sutha, et al.
Pageof 36